[go: up one dir, main page]

AU2019902527A0 - Compositions and methods of use - Google Patents

Compositions and methods of use

Info

Publication number
AU2019902527A0
AU2019902527A0 AU2019902527A AU2019902527A AU2019902527A0 AU 2019902527 A0 AU2019902527 A0 AU 2019902527A0 AU 2019902527 A AU2019902527 A AU 2019902527A AU 2019902527 A AU2019902527 A AU 2019902527A AU 2019902527 A0 AU2019902527 A0 AU 2019902527A0
Authority
AU
Australia
Prior art keywords
compositions
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2019902527A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baker IDI Heart and Diabetes Institute
Original Assignee
Baker IDI Heart and Diabetes Institute
Filing date
Publication date
Application filed by Baker IDI Heart and Diabetes Institute filed Critical Baker IDI Heart and Diabetes Institute
Publication of AU2019902527A0 publication Critical patent/AU2019902527A0/en
Priority to BR112022000814A priority Critical patent/BR112022000814A2/en
Priority to AU2020314798A priority patent/AU2020314798A1/en
Priority to CA3147249A priority patent/CA3147249A1/en
Priority to PCT/AU2020/050742 priority patent/WO2021007623A1/en
Priority to JP2022503457A priority patent/JP2022541277A/en
Priority to KR1020227005189A priority patent/KR20220047775A/en
Priority to EP20839957.6A priority patent/EP3999044A4/en
Priority to MX2022000664A priority patent/MX2022000664A/en
Priority to CN202080065491.1A priority patent/CN114502149A/en
Priority to US17/597,659 priority patent/US20220257616A1/en
Priority to IL289859A priority patent/IL289859A/en
Abandoned legal-status Critical Current

Links

AU2019902527A 2019-07-17 2019-07-17 Compositions and methods of use Abandoned AU2019902527A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
US17/597,659 US20220257616A1 (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject
JP2022503457A JP2022541277A (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating a mixture of ether lipid molecules in tissues of human subjects
AU2020314798A AU2020314798A1 (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject
CA3147249A CA3147249A1 (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject
PCT/AU2020/050742 WO2021007623A1 (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject
BR112022000814A BR112022000814A2 (en) 2019-07-17 2020-07-17 Composition, method of maintaining ether lipids, method of evaluating an individual, method of treatment or prevention, method of preventing asthma, use of a composition
KR1020227005189A KR20220047775A (en) 2019-07-17 2020-07-17 A composition for maintaining or modulating a mixture of ether lipid molecules in a tissue of a human subject
EP20839957.6A EP3999044A4 (en) 2019-07-17 2020-07-17 COMPOSITIONS FOR MAINTAINING OR MODULATING MIXTURES OF ETHERLIPID MOLECULES IN A HUMAN TISSUE
MX2022000664A MX2022000664A (en) 2019-07-17 2020-07-17 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject.
CN202080065491.1A CN114502149A (en) 2019-07-17 2020-07-17 Composition for maintaining or regulating a mixture of ether lipid molecules in human tissue
IL289859A IL289859A (en) 2019-07-17 2022-01-15 Compositions for maintaining or modulating mixtures of ether lipid molecules in a tissue of a human subject

Publications (1)

Publication Number Publication Date
AU2019902527A0 true AU2019902527A0 (en) 2019-08-01

Family

ID=

Similar Documents

Publication Publication Date Title
EP4022059A4 (en) Oligonucleotide compositions and methods of use thereof
EP3965780A4 (en) Oligonucleotide compositions and methods of use thereof
EP3790596A4 (en) Oligonucleotide compositions and methods of use thereof
EP3976638A4 (en) Il-2 compositions and methods of use thereof
EP3997115A4 (en) Il-2 compositions and methods of use thereof
EP3843720A4 (en) Compositions of cxcr4 inhibitors and methods of preparation and use
EP3624773A4 (en) Ophthalmic compositions and methods of use
EP3893917A4 (en) Il-15 compositions and methods of use thereof
EP3829307A4 (en) Bismuth-thiol compositions and methods of use
EP3917543A4 (en) Enhanced nitrate compositions and methods of use
EP3843729A4 (en) Novel compositions and methods
EP3802553A4 (en) Silicon-containing compositions and their methods of use
EP3740576A4 (en) Therapeutic compositions and methods of making and using the same
EP4081231A4 (en) Compositions comprising microbes and methods of use and making thereof
EP3934426A4 (en) Preservative compositions and methods of use thereof
EP3606493A4 (en) Dental cement compositions and methods of use
EP3768315A4 (en) Fc variant compositions and methods of use thereof
EP4045226A4 (en) Polishing compositions and methods of use thereof
EP3793563A4 (en) Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds and methods of use thereof
EP3601460A4 (en) Polishing compositions and methods of use thereof
EP3774708A4 (en) Foxm1 inhibitor compositions and methods of using the same
AU2018292381A1 (en) Cosmetic compositions and methods of use
EP4142740A4 (en) Compositions and methods of use thereof
EP4381022A4 (en) Compositions and methods of use thereof
EP4054514A4 (en) Compositions containing fenchols and methods of use